Información del producto
- Cyclosporine A-d4
- Cyclosporina
- Cyclosporine
- Cyclosporin
- Restasis
- cyclosporin A
- Antibiotic S 7481F1
- 30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-3,21-bis(1-methylethyl)-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-3,21-bis(1-methylethyl)-6,9,18,24-tetrakis(2-methylpropyl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- 1: PN: US6686454 SEQID: 1 claimed protein
- Ver más sinónimos
- 7: PN: WO0002548 PAGE: 30 claimed protein
- Arpimune ME
- Cicloral
- Cicloral (antibiotic)
- Ciclosporin
- Cipol N
- Consupren
- Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl]
- Debio088
- Equoral
- Gengraf
- Neoplanta
- Neoral
- Nsc 290193
- Ol 27-400
- Papilock Mini
- Ramihyphin A
- Sandimmun
- Sandimmune
- Sandimmune Neoral
- Sang-35
- SangCyA
- Sdz-Oxl 400
- Sigmasporin Microoral
- S-Neoral
- Zinograf ME
- Sandimmun Neoral
Applications An immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection.A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),
Propiedades químicas
Consulta técnica sobre: TR-C988902 Cyclosporin A-d4 (Major)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.